These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 25828724)
1. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide. Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724 [TBL] [Abstract][Full Text] [Related]
2. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751 [TBL] [Abstract][Full Text] [Related]
3. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126 [TBL] [Abstract][Full Text] [Related]
4. [Radioembolization with (90)Y-microspheres for liver tumors]. Rodríguez-Fraile M; Iñarrairaegui M Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062 [No Abstract] [Full Text] [Related]
5. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma. Wehrenberg-Klee E; Gandhi RT; Ganguli S Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713 [TBL] [Abstract][Full Text] [Related]
6. Imaging of Hepatocellular Carcinoma Response After Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955 [TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. Riaz A; Lewandowski RJ; Kulik L; Salem R Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310 [TBL] [Abstract][Full Text] [Related]
8. Invited commentary. Salem R J Vasc Interv Radiol; 2011 Oct; 22(10):1362-3. PubMed ID: 21961980 [No Abstract] [Full Text] [Related]
9. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479 [TBL] [Abstract][Full Text] [Related]
11. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Aug; 17(8):1251-78. PubMed ID: 16923973 [TBL] [Abstract][Full Text] [Related]
12. Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques. Malhotra A; Liu DM; Talenfeld AD Tech Vasc Interv Radiol; 2019 Jun; 22(2):49-57. PubMed ID: 31079710 [TBL] [Abstract][Full Text] [Related]
13. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920 [TBL] [Abstract][Full Text] [Related]
14. ⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments. Braat AJ; Smits ML; Braat MN; van den Hoven AF; Prince JF; de Jong HW; van den Bosch MA; Lam MG J Nucl Med; 2015 Jul; 56(7):1079-87. PubMed ID: 25952741 [TBL] [Abstract][Full Text] [Related]
15. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma. Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747 [TBL] [Abstract][Full Text] [Related]
16. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment. Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725 [TBL] [Abstract][Full Text] [Related]
17. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma. Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647 [TBL] [Abstract][Full Text] [Related]
18. Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models. Mikell JK; Dewaraja YK; Owen D Semin Radiat Oncol; 2020 Jan; 30(1):68-76. PubMed ID: 31727302 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications. Gates VL; Salem R; Lewandowski RJ J Vasc Interv Radiol; 2013 Aug; 24(8):1153-5. PubMed ID: 23885913 [No Abstract] [Full Text] [Related]
20. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]